Delivery Order SPE2DB20D2104-SPE2DB25FMBVP

Award Date 11/12/24
Potential Completion Date 11/13/24
Potential Value $6.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a Delivery Order valued at $6,012.50 for the supply of XELJANZ XR 11 MG TABLET UU 30S. The contract is issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 18, 2025. The contract is a Firm Fixed Price arrangement with no set-aside requirements indicated. AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,940.91 firm-fixed-price delivery order is for the supply of XELJANZ XR 11 MG TABLET medication. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,758.13 fixed-price delivery order is for the supply of XELJANZ XR 11 MG TABLET UU 30S, a specialty medication. The contract has an ultimate completion date of January 17, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $91,750.91. The contract, awarded by the Defense Logistics Agency (DLA), is for the supply of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of April 21, 2023 and is a firm fixed price contract. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, valued at $6,882.07, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price and covers the supply of XELJANZ XR 11 MG TABLET for the government. The award has an ultimate completion date of December 6, 2024. This contract is not set aside for any specific business category. AmerisourceBergen holds a significant...
This federal contract award to AmerisourceBergen Drug Corp is a delivery order worth $17,247.01 for the supply of XELJANZ XR 11 MG TABLET. The contract is awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 2, 2023. The contract is a firm fixed price type and does not have any set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,118.90 firm fixed-price delivery order is for the supply of XELJANZ XR 11 MG TABLET, a specialty medication. The contract has an ultimate completion date of December 3, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,578.25 fixed-price delivery order is for the supply of XELJANZ XR 11 MG TABLET UU 30S, a prescription medication. The contract has an ultimate completion date of June 14, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,243.13 firm fixed-price delivery order is for the supply of XELJANZ XR 11 MG Tablets, a prescription medication. The contract has an ultimate completion date of June 4, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,255.70 firm fixed-price delivery order is for the supply of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of February 11, 2025 and was awarded on February 10, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMBVP
    Delivery Order

This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA) for the supply of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product. The contract is a Delivery Order valued at $6,090.21 with a firm fixed price. It does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The current award is likely a task order or delivery order placed against this larger IDC contract.

Generated 5/20/25, 1:47 PM